Precision medicine in diabetes prevention, classification and management

Area of Science:

• Genomics
• Precision Medicine
• Diabetes Research

Background:

• Diabetes management faces challenges with uniform treatment algorithms, leading to treatment failure and complications.
• Genomic architecture understanding provides a basis for personalized diabetes care.
• Healthcare expenditure for diabetes is a significant global burden.

Purpose of the Study:

• To review recent advances in understanding the genetic basis of diabetes and its complications.
• To provide a clinician's perspective on the utility of genomic medicine in diabetes care.
• To discuss the translation of genetic findings into clinical practice for personalized diabetes management.

Main Methods:

• Review of recent scientific literature on diabetes genetics and genomics.
• Analysis of the clinical utility of genetic information in diabetes management.
• Exploration of pharmacogenetics and multi-omic approaches in diabetes research.

Main Results:

• Genetic information is most effectively used in managing monogenic diabetes.
• Advances in genetic research for diabetes, its complications, and pharmacogenetics are significant.
• Translating genetic findings into practice requires risk prediction models and multi-omic analyses.

Conclusions:

• Genomic medicine holds promise for personalizing diabetes prevention and management.
• Further research is needed to integrate genetic information into clinical decision-making.
• Empowering individuals and healthcare professionals with genetic data is key to optimal diabetes outcomes.